According to the Zhitong Finance App, Corning Jerry Pharmaceutical-B (09966) announced that on August 28, 2026, the board of directors decided to repurchase the company's common shares from the open market from time to time, with a maximum amount of HK$80 million.

The board of directors believes that the current transaction price of the shares does not accurately reflect the company's intrinsic value. It also believes that this share repurchase will reflect the company's confidence in its own business outlook and prospects, and ultimately benefit the company and create value for shareholders. The Board believes that the company's current financial resources are sufficient to support the proposed share repurchases and maintain a sound financial position.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.